GHTC’s director Jamie Bay Nishi was invited by the White House to deliver video remarks for the Global COVID-19 Summit held on September 22, 2021.
Learn more
GHTC sent a letter to the White House Office of Management and Budget (OMB), calling for the administration to sustain and protect global health R&D in the fiscal year 2022 (FY22) budget.
PDF
GHTC co-signed a letter to House and Senate Appropriations Committee leadership urging Congress to expediently allocate funding from the American Rescue Plan Act to support the vaccine development activities of the Coalition for Epidemic Preparedness Innovations (CEPI).
PDF
GHTC endorsed a call-to-action letter from the G20 Health and Development Partnership to Italian Prime Minister Mario Draghi outlining urgent actions the G20 should take to improve health security
View
GHTC joined a coalition of more than 80 global leaders and 25 cross-sector organizations in calling on world leaders attending the United Nations General Assembly to convene a global summit to ignite an urgent global action plan to end the COVID-19 pandemic.
View
GHTC has endorsed a framework developed by the Pandemic Action Network and partners outlining a global action plan for COVID-19 response. The framework calls on world leaders to urgently convene a "Global Pandemic Response and Vaccination Summit" and commit to urgent actions to bolster the global COVID-19 response.
PDF
GHTC endorses letters from the Global Health Council's Tuberculosis (TB) Roundtable to Senate appropriators urging funding increases for TB programs in the fiscal year funding bills for State and Foreign Operations (SFOPS) and Labor, Health and Human Services (LHHS).
Learn more
GHTC delivered a statement at a US Department of Health and Human Services (HHS) stakeholder listening session urging the US delegation to prioritize R&D capacity strengthening within global frameworks to strengthen pandemic preparedness. The statement—which will inform US engagement in the member state working group on strengthening the World Health Organization’s (WHO) preparedness and response to health emergencies—calls for the inclusion of R&D capacity strengthening within implementation of the International Health Regulations, the expansion of regional manufacturing capacities, and enshrinement of R&D coordination and financing mechanisms as part of any future pandemic treaty.
Learn more
GHTC shapes and endorsed recommendations from the Pandemic Action Network (PAN) to inform the review of the Access to COVID-19 Tools Accelerator (ACT-A)
View
GHTC Director Jamie Bay Nishi provided remarks during a listening session hosted by the National Institutes of Health and the White House Office of Science and Technology Policy on the proposed Advanced Research Projects Agency for Health (ARPA-H). The statement argues that if the goal for ARPA-H is to produce transformative innovations where there otherwise would be none, poverty-related and neglected diseases are an area with high potential impact.
Learn more